ENDOLOGIX INC's ticker is and the CUSIP is 29266SAB2.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $34,452,000 | +1.7% | 47,379,000 | 0.0% | 0.76% | -15.4% |
| Q4 2018 | $33,876,000 | +2.3% | 47,379,000 | 0.0% | 0.90% | +85.6% |
| Q3 2018 | $33,103,000 | -24.0% | 47,379,000 | 0.0% | 0.48% | -28.9% |
| Q2 2018 | $43,539,000 | +5.7% | 47,379,000 | -0.6% | 0.68% | -18.5% |
| Q1 2018 | $41,210,000 | +4.1% | 47,642,000 | +9.8% | 0.84% | -10.9% |
| Q4 2017 | $39,584,000 | +12.6% | 43,409,000 | +7.4% | 0.94% | +35.9% |
| Q3 2017 | $35,156,000 | +113.4% | 40,409,000 | +111.1% | 0.69% | +55.6% |
| Q2 2017 | $16,473,000 | -4.2% | 19,141,000 | +10.5% | 0.44% | +3.0% |
| Q1 2017 | $17,197,000 | – | 17,316,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 5,575,000 | $5,504,000 | 4.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 40,500,000 | $40,013,000 | 1.54% |
| PFM Health Sciences, LP | 17,316,000 | $17,197,000 | 0.43% |
| LINDEN ADVISORS LP | 11,639,000 | $11,511,000 | 0.43% |
| Partner Investment Management, L.P. | 309,000 | $307,000 | 0.37% |
| WOLVERINE ASSET MANAGEMENT LLC | 20,905,000 | $20,591,000 | 0.32% |
| SSI INVESTMENT MANAGEMENT LLC | 3,256,000 | $3,217,000 | 0.30% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 1,500,000 | $1,490,000 | 0.14% |
| AMUNDI ASSET MANAGEMENT US, INC. | 7,000,000 | $6,917,000 | 0.02% |
| Citadel Advisors | 16,800,000 | $16,555,000 | 0.02% |